Key Takeaway: The .25 mg dose is designed to help your body adjust to the medication safely, setting a foundation for higher doses later in your treatment program
Further studies are needed to enhance our understanding of its therapeutic potential that could pave the way for targeted interventions in the management of not only chronic liver diseases, but other inflammatory bowel diseases or systemic inflammatory conditions
Nausea, vomiting, and diarrhoeareported by a substantial proportion of patients, especially during treatment initiationresult in the loss of not only water but also essential electrolytes, particularly sodium, potassium, and chloride
Seminars in Reproductive Medicine, 41 (3-04), 108-118
Difficult IV access is more common than you'd think